Foghorn Therapeutics Inc. (FHTX)

4.31

-0.54 (-11.13%)

At close: Mar 03, 2025, 3:59 PM

4.32

0.23%

After-hours: Mar 03, 2025, 04:00 PM EST

Foghorn Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-98.43M	-108.88M	-101.32M	-68.8M	-51.13M	-26.34M
Depreciation & Amortization	3.45M	3.32M	3.23M	1.33M	693K	379K
Stock-Based Compensation	16.19M	14.34M	8.38M	2.96M	1.69M	732K
Other Working Capital	-42.73M	-20.07M	336.48M	28.23M	-14K	1.15M
Other Non-Cash Items	2.56M	3.29M	4.61M	4.44M	1.2M	124K
Deferred Income Tax	n/a	n/a	1.41M	84K	10K	30K
Change in Working Capital	-41.88M	281.55M	33.44M	28.7M	1.2M	2.42M
Operating Cash Flow	-118.11M	193.61M	-50.25M	-31.29M	-46.34M	-22.65M
Capital Expenditures	-1.22M	-1.21M	-3.31M	-16.18M	-968K	-1.54M
Acquisitions	n/a	243.11M	-39.49M	250K	4K	n/a
Purchase of Investments	-73.9M	-409.35M	-99.98M	-92.98M	n/a	n/a
Sales Maturities Of Investments	219.57M	166.23M	139.47M	-250K	n/a	n/a
Other Investing Acitivies	n/a	-243.11M	39.49M	250K	4K	n/a
Investing Cash Flow	144.45M	-244.32M	36.17M	-108.91M	-964K	-1.54M
Debt Repayment	n/a	n/a	-21.2M	4.27M	7.98M	11.14M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.78M	1.76M	1.42M	91.08M	15.98M	40.63M
Financial Cash Flow	1.78M	1.76M	22.42M	217.47M	23.97M	51.77M
Net Cash Flow	28.12M	-48.95M	8.34M	77.27M	-23.33M	27.58M
Free Cash Flow	-119.33M	192.4M	-53.56M	-47.47M	-47.3M	-24.19M